the point is
the point is
dedication

Together with eye care professionals, we’re rethinking what’s possible

About Tenpoint Therapeutics

Our mission is to address the unmet needs of aging eyes

Our vision

We see things differently. We are addressing the most pressing challenges in major ophthalmic conditions with the highest unmet need and greatest global market potential.

At Tenpoint Therapeutics, we’re rejuvenating vision for the aging eye. We envision a world where everyone enjoys a lifetime of clear vision. By understanding real-world needs and partnering with eye care professionals, we’re setting a new standard for presbyopia care. Presbyopia is just the beginning.

The leadership of Tenpoint Therapeutics is backed by
more than 150 combined years of experience

Committed to delivering lasting clinical impact to patients in need, our leadership team and board of directors bring a powerful blend
of global capabilities, extensive ophthalmic experience, and collaborative spirit to everything we do.

Our leadership team

Headshot of Ben Bergo, Tenpoint Therapeutics™

BEN BERGO

President,
Chief Business Officer

BEN BERGO
Headshot of Henric Bjarke, Tenpoint Therapeutics™

HENRIC BJARKE

Chief Executive Officer

HENRIC BJARKE
Headshot of Esther Cuno, Tenpoint Therapeutics™

ESTHER CUNO

Vice President of
Human Resources

ESTHER CUNO
Headshot of Melissa Epperly, Tenpoint Therapeutics™

MELISSA EPPERLY

Chief Financial Officer

MELISSA EPPERLY

STEPHEN S. LANE, MD

Chief Medical Officer

STEPHEN S. LANE, MD
Headshot of Tim Grinstead, Tenpoint Therapeutics™

TIM GRINSTEAD

Chief Operating Officer

TIM GRINSTEAD
Headshot of Carol Kearney, Tenpoint Therapeutics™

CAROL KEARNEY

Chief Commercial Officer

CAROL KEARNEY
Headshot of Yemisi Corinaldi, Tenpoint Therapeutics™

YEMISI CORINALDI

Vice President of Regulatory Affairs

YEMISI CORINALDI

Our board of directors

Headshot of David Guyer, Tenpoint Therapeutics™

DAVID GUYER, MD

Chairman of the Board

Headshot of Henric Bjarke, Tenpoint Therapeutics™

HENRIC BJARKE

Chief Executive Officer

Headshot of John De Koning, Tenpoint Therapeutics™

JOHN DE KONING, PhD

Director

Headshot of Eric D. Donnenfeld, Tenpoint Therapeutics™

ERIC D. DONNENFELD, MD

Director

CARMINE CIRCELLI

Director

Headshot of Jim Mazzo, Tenpoint Therapeutics™

JIM MAZZO

Director

Headshot of Alexander Pasteur, Tenpoint Therapeutics™

ALEXANDER PASTEUR

Director

Headshot of Graziano Seghezzi, Tenpoint Therapeutics™

GRAZIANO SEGHEZZI

Director

Headshot of Tracy M. Valorie, Tenpoint Therapeutics™

TRACY M. VALORIE

Director

Headshot of Zichao (Jason) Zhang, Tenpoint Therapeutics™

ZICHAO (JASON) ZHANG

Director

Ethics and Compliance

Tenpoint Therapeutics is committed to conducting business in a manner that is ethical, sustainable, and responsible. Our approach is guided by industry best practices, as well as government statements and expectations regarding effective risk management. We strive to bring innovation to the aging eye, and we believe a company founded on ethics and integrity is critical to our success.

Core Elements of Our Ethics and Compliance Program

The Tenpoint Therapeutics Ethics and Compliance program consists of seven fundamental elements that serve as the foundation for our risk management efforts. These elements are consistently reviewed and refined to ensure they remain aligned with evolving business strategies, current practices, and changes in the external environment.

Tenpoint Therapeutics has an appointed Compliance Officer who is responsible for developing, operating, and monitoring the Comprehensive Compliance Program (CCP). A Compliance Committee has also been formed to assist with CCP implementation.

We establish and maintain policies and procedures that provide clear expectations for ethical and compliant conduct for all employees.

Training and education is provided to all Tenpoint Therapeutics employees and helps them understand applicable requirements and their role in supporting compliance.

The company uses various internal communication tools to address compliance topics with employees. We promote a culture in which questions can be raised, issues are addressed at company meetings, guidance can be sought, and concerns can be reported through appropriate channels.

Routine compliance monitoring and audits are conducted to help identify issues and evaluate program effectiveness. This ongoing enhancement process holds us accountable and enables us to respond effectively to new challenges and opportunities within the compliance landscape. In addition, we conduct compliance risk assessments periodically to enable the organization to comply with applicable laws and regulations.

The CCP mandates prompt responses to potential violations of law, regulation, industry codes, or company policies. Each potential violation is investigated and evaluated individually. When appropriate, disciplinary action—including termination—is taken.

Upon investigation of reported or detected compliance issues, the company assesses whether additional corrective actions are warranted.

Tenpoint Therapeutics Code of Conduct

Our Code of Conduct sets expectations for employees and everyone who conducts business on behalf of Tenpoint Therapeutics and describes how we interact with our colleagues, customers, vendors, and patients with integrity and compliance. New employees are required to complete training on the Code of Conduct upon joining Tenpoint Therapeutics.

The Code and related trainings include instructions on how employees and other individuals can report concerns, including through the Tenpoint Ethics Hotline—a third-party vendor that is available 24/7. Failure to comply with our Code of Conduct, Tenpoint Therapeutics policies, or applicable laws can result in disciplinary and corrective action, up to and including termination of employment, or termination of contractual relationships, where applicable.

State Prescriber Information

Supporting Our Purpose

The Ethics and Compliance Program supports the Tenpoint Therapeutics broader mission by fostering an environment that encourages innovation, advances our purpose, and delivers positive outcomes for all patients and stakeholders involved. Through this program, we reinforce our dedication to responsible business practices and ethical conduct throughout the organization.

red circle with white x click to close pop-up window
red circle with white x click to close pop-up window
Tenpoint branded circle

You are now leaving tenpointtherapeutics.com.
Are you sure you want to continue?